Etoposide

NDC 0378-3266 · Mylan Pharmaceuticals Inc.

Generic nameetoposide

Dosage formCAPSULE

RouteORAL

Active ingredient(s)ETOPOSIDE

Strength50 mg/1

Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]

Marketing categoryANDA

Packages

0378-3266-94 — 20 CAPSULE in 1 CARTON (0378-3266-94)

J8560 — Etoposide; oral, 50 mg Medicare Part B payment limit (ASP + 6%): $88.06

FDA lists these products with the same active ingredient.

0143-9376 — Etoposide, 0143-9510 — Etoposide, 0143-9511 — Etoposide, 0143-9512 — Etoposide, 16729-114 — Etoposide, 63323-104 — ETOPOSIDE, 68001-265 — Etoposide, 68001-681 — Etoposide, 68001-682 — Etoposide, 68001-683 — Etoposide, 69238-2811 — Etoposide, 71288-175 — Etoposide, 71288-176 — Etoposide, 71288-177 — Etoposide, 83270-451 — ETOPOSIDE, 83831-144 — etoposide, 83831-145 — etoposide

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.